Department of Neurology, Cerebral Vascular Disease Research Laboratories, University of Miami, Miller School of Medicine, Two Story Laboratory (TSL), Medical Campus, Miami, Florida, USA.
Department of Critical Care Medicine, Safar Center for Resuscitation Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
J Cereb Blood Flow Metab. 2014 Apr;34(4):613-20. doi: 10.1038/jcbfm.2013.232. Epub 2014 Jan 22.
We previously showed that inhibition of protein kinase C delta (PKCδ) improves brain perfusion 24 hours after asphyxial cardiac arrest (ACA) and confers neuroprotection in the cortex and CA1 region of the hippocampus 7 days after arrest. Therefore, in this study, we investigate the mechanism of action of PKCδ-mediated hypoperfusion after ACA in the rat by using the two-photon laser scanning microscopy (TPLSM) to observe cortical cerebral blood flow (CBF) and laser Doppler flowmetry (LDF) detecting regional CBF in the presence/absence of δV1-1 (specific PKCδ inhibitor), nitric oxide synthase (NOS) substrate (L-arginine, L-arg) and inhibitor (N(ω)-Nitro-L-arginine, NLA), and nitric oxide (NO) donor (sodium nitroprusside, SNP). There was an increase in regional LDF and local (TPLSM) CBF in the presence of δV1-1+L-arg, but only an increase in regional CBF under δV1-1+SNP treatments. Systemic blood nitrite levels were measured 15 minutes and 24 hours after ACA. Nitrite levels were enhanced by pretreatment with δV1-1 30 minutes before ACA possibly attributable to enhanced endothelial NOS protein levels. Our results suggest that PKCδ can modulate NO machinery in cerebral vasculature. Protein kinase C delta can depress endothelial NOS blunting CBF resulting in hypoperfusion, but can be reversed with δV1-1 improving brain perfusion, thus providing subsequent neuroprotection after ACA.
我们之前的研究表明,抑制蛋白激酶 C 德尔塔(PKCδ)可改善窒息性心脏骤停(ACA)后 24 小时的脑灌注,并在 ACA 后 7 天提供大脑皮层和海马 CA1 区的神经保护作用。因此,在本研究中,我们通过使用双光子激光扫描显微镜(TPLSM)观察皮层脑血流(CBF),并使用激光多普勒流量仪(LDF)检测局部 CBF,以研究 PKCδ 在 ACA 后低灌注的作用机制。我们检测了 δV1-1(特异性 PKCδ 抑制剂)、一氧化氮合酶(NOS)底物(L-精氨酸,L-arg)和抑制剂(N(ω)-硝基-L-精氨酸,NLA)以及一氧化氮(NO)供体(硝普钠,SNP)存在/不存在的情况下,区域性 CBF。在 δV1-1+L-arg 存在的情况下,局部(TPLSM)CBF 和区域性 LDF 增加,但只有在 δV1-1+SNP 处理下才增加了区域性 CBF。在 ACA 后 15 分钟和 24 小时测量了全身血硝酸盐水平。在 ACA 前 30 分钟用 δV1-1 预处理可增强硝酸盐水平,可能归因于增强的内皮型一氧化氮合酶蛋白水平。我们的结果表明,PKCδ 可以调节脑血管中的 NO 机制。蛋白激酶 C 德尔塔(PKCδ)可抑制内皮型一氧化氮合酶,使 CBF 降低导致低灌注,但可通过 δV1-1 改善脑灌注而逆转,从而在 ACA 后提供后续的神经保护作用。